Search
Search Results
##search.searchResults.foundPlural##
-
INFECTIOUS COMPLICATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA
3209PDF: 1309HTML: 2608 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1256PDF: 771HTML: 294 -
PERSISTENT COLONIC SCHISTOSOMIASIS AMONG SYMPTOMATIC RURAL INHABITANTS IN THE EGYPTIAN NILE DELTA Colonic schistosomiasis among rurals of the Egyptian Nile delta
1387PDF: 448MP4: 381Html: 177 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4192PDF: 1333HTML: 2025 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2075PDF: 842HTML: 300 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4130PDF: 1486HTML: 426 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1237PDF: 531Suppl. Files: 326HTML: 128 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2738PDF: 979HTML: 5497 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3767PDF: 1410HTML: 8486 -
ANTIFUNGAL THERAPY IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
4649PDF: 1509HTML: 2229Untitled: 189Untitled: 204Untitled: 211Untitled: 195Untitled: 196 -
RECENT ADVANCES IN THE 5Q- SYNDROME
2683PDF: 1754HTML: 3633Pellagatti Fig 1: 188Pellagatti Fig. 2: 188 -
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1182PDF: 699HTML: 291 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3308PDF: 1263HTML: 1846Fig.1: 182Fig. 2: 188 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2371HTML: 252PDF: 822 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4337PDF: 1871HTML: 17709 -
Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and G-CSF
1682PDF: 545HTML: 261 -
THE ROLE OF AUTOLOGOUS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN FOLLICULAR LYMPHOMA IN THE NEW DRUGS ERA.
3973PDF: 1115HTML: 1916Fig.1: 204Fig. 2: 102Table 1: 184Table2: 199Table 3: 181 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3229PDF: 1430HTML: 3975 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7197PDF: 2372HTML: 1705Table 1.: 183Table 2.: 199Table 3.: 180Table 4.: 179 -
Severe immune thrombocytopenia (ITP) following SARS-CoV-2 mRNA vaccine in a girl on immunosuppressive treatment and in prolonged stable phase of ITP. immune thrombocytopenia following mRNA vaccine
2056PDF: 516HTML: 1128 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
2973PDF: 836HTML: 7150Kost Fig1: 164Kost Fig 2: 156Kost Fig3: 151Kost Fig 4: 169Kost Fig5: 166Kost fig 6: 151 -
-
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2315PDF: 963HTML: 1628Fig 1: 167Tab I: 191Cover Letter: 182 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2075PDF: 1524HTML: 248 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5050PDF: 1288HTML: 2725Cover letter: 174 -
DEMOGRAPHICAL, VIRO-IMMUNOLOGICAL, CLINICAL AND THERAPEUTICAL CHARACTERISTICS OF HIV INFECTED PATIENTS IN A “EPIDEMIOLOGICALLY UNEXPLORED” REGION OF ITALY (CALABRIA REGION): THE CALABRHIV COHORT.
1554PDF: 765HTML: 1219Figure 1: 149Figure 2: 168Figure 3: 165 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4538PDF: 2731HTML: 2245 -
How I treat acute and persistent sickle cell pain
1836PDF: 1087HTML: 460 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
2805PDF: 1308HTML: 3551Untitled: 171Untitled: 186Untitled: 162







